177 related articles for article (PubMed ID: 9366523)
21. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
Casagrande G; te Kronnie G; Basso G
Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
[TBL] [Abstract][Full Text] [Related]
22. CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal.
Chen W; Yu YL; Lee SF; Chiang YJ; Chao JR; Huang JH; Chiong JH; Huang CJ; Lai MZ; Yang-Yen HF; Yen JJ
Mol Cell Biol; 2001 Jul; 21(14):4636-46. PubMed ID: 11416141
[TBL] [Abstract][Full Text] [Related]
23. The Hox cooperativity motif of the chimeric oncoprotein E2a-Pbx1 is necessary and sufficient for oncogenesis.
Chang CP; de Vivo I; Cleary ML
Mol Cell Biol; 1997 Jan; 17(1):81-8. PubMed ID: 8972188
[TBL] [Abstract][Full Text] [Related]
24. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
[TBL] [Abstract][Full Text] [Related]
25. The role of E2A-PBX1 in leukemogenesis.
Aspland SE; Bendall HH; Murre C
Oncogene; 2001 Sep; 20(40):5708-17. PubMed ID: 11607820
[No Abstract] [Full Text] [Related]
26. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
[TBL] [Abstract][Full Text] [Related]
27. E2A-HLF usurps control of evolutionarily conserved survival pathways.
Seidel MG; Look AT
Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
[TBL] [Abstract][Full Text] [Related]
28. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
[TBL] [Abstract][Full Text] [Related]
29. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor.
Inaba T; Inukai T; Yoshihara T; Seyschab H; Ashmun RA; Canman CE; Laken SJ; Kastan MB; Look AT
Nature; 1996 Aug; 382(6591):541-4. PubMed ID: 8700228
[TBL] [Abstract][Full Text] [Related]
30. Cell transformation mediated by homodimeric E2A-HLF transcription factors.
Inukai T; Inaba T; Yoshihara T; Look AT
Mol Cell Biol; 1997 Mar; 17(3):1417-24. PubMed ID: 9032268
[TBL] [Abstract][Full Text] [Related]
31. [Detection of fusion genes resulting from chromosome abnormalities in childhood acute lymphoblastic leukemia].
He J; Chen ZX; Xue YQ; Li JQ; He HL; Huang YP; He YX; Chai YH; Zhu LL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):551-3. PubMed ID: 16215946
[TBL] [Abstract][Full Text] [Related]
32. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
[TBL] [Abstract][Full Text] [Related]
33. DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein.
Inaba T; Shapiro LH; Funabiki T; Sinclair AE; Jones BG; Ashmun RA; Look AT
Mol Cell Biol; 1994 May; 14(5):3403-13. PubMed ID: 8164688
[TBL] [Abstract][Full Text] [Related]
34. [Childhood acute lymphoblastic leukemia with t(1;19) lacking E2A-pBX1 chimeric transcripts].
Matsubara K; Hirata T
Rinsho Ketsueki; 2005 Jan; 46(1):7-12. PubMed ID: 16708911
[TBL] [Abstract][Full Text] [Related]
35. Pre-B-cell leukemia transcription factor 1 is a major target of promyelocytic leukemia zinc-finger-mediated melanoma cell growth suppression.
Shiraishi K; Yamasaki K; Nanba D; Inoue H; Hanakawa Y; Shirakata Y; Hashimoto K; Higashiyama S
Oncogene; 2007 Jan; 26(3):339-48. PubMed ID: 16862184
[TBL] [Abstract][Full Text] [Related]
36. Identification of a new type of PBX1 partner that contains zinc finger motifs and inhibits the binding of HOXA9-PBX1 to DNA.
Laurent A; Bihan R; Deschamps S; Guerrier D; Dupé V; Omilli F; Burel A; Pellerin I
Mech Dev; 2007 May; 124(5):364-76. PubMed ID: 17353115
[TBL] [Abstract][Full Text] [Related]
37. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
38. The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF.
Inukai T; Inaba T; Ikushima S; Look AT
Mol Cell Biol; 1998 Oct; 18(10):6035-43. PubMed ID: 9742120
[TBL] [Abstract][Full Text] [Related]
39. Pim1 cooperates with E2a-Pbx1 to facilitate the progression of thymic lymphomas in transgenic mice.
Feldman BJ; Reid TR; Cleary ML
Oncogene; 1997 Nov; 15(22):2735-42. PubMed ID: 9401000
[TBL] [Abstract][Full Text] [Related]
40. Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.
Lee YL; Ito K; Pi WC; Lin IH; Chu CS; Malik S; Cheng IH; Chen WY; Roeder RG
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33542097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
